Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT01542879
PHASE1/PHASE2

Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

Sponsor: Heike E Daldrup-Link

View on ClinicalTrials.gov

Summary

A research study on the diagnosis of spread of disease for children who have been diagnosed with solid tumors using a new whole body imaging technique and a new MR contrast agent (ferumoxytol). Standard tests that are used to determine the extent and possible spread of a child's disease include magnetic resonance (MR) imaging, computed tomography (CT), Positron Emission Tomography (PET) as well as bone scanning, and metaiodobenzylguanidine (MIBG) scanning. The purpose of this study is to determine if newer imaging tests referred to as whole body diffusion-weighted MR and whole body PET/MR can detect the extent and spread of the disease as accurately or even better as the standard tests (CT, MR and/or PET/CT). The advantage of the new imaging test is that it is associated with no or significantly reduced radiation exposure compared to standard CT and PET/CT imaging tests. The results of whole body MR and PET/MR will be compared with that of the conventional, standard imaging studies for tumor detecting.

Official title: Development of Radiation Free Whole Body MR Imaging Technique for Staging of Children With Cancer.

Key Details

Gender

All

Age Range

6 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2012-02

Completion Date

2026-12

Last Updated

2024-11-25

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

WB-DW-MR scan

WB-DW-MR scans will be obtained on a 3T PET-MR system

PROCEDURE

18-F-FDG PET scan

DRUG

Ferumoxytol

PROCEDURE

18-F-FDG PET/MR scan

Locations (1)

Stanford University Cancer Institute

Stanford, California, United States